292 related articles for article (PubMed ID: 30923898)
1. Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades' résumé.
Krmpotić A; Podlech J; Reddehase MJ; Britt WJ; Jonjić S
Med Microbiol Immunol; 2019 Aug; 208(3-4):415-429. PubMed ID: 30923898
[TBL] [Abstract][Full Text] [Related]
2. Cellular reservoirs of latent cytomegaloviruses.
Reddehase MJ; Lemmermann NAW
Med Microbiol Immunol; 2019 Aug; 208(3-4):391-403. PubMed ID: 31011793
[TBL] [Abstract][Full Text] [Related]
3. Human Cytomegalovirus Latency: Approaching the Gordian Knot.
Goodrum F
Annu Rev Virol; 2016 Sep; 3(1):333-357. PubMed ID: 27501258
[TBL] [Abstract][Full Text] [Related]
4. A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells.
Liu XF; Swaminathan S; Yan S; Engelmann F; Abbott DA; VanOsdol LA; Heald-Sargent T; Qiu L; Chen Q; Iovane A; Zhang Z; Abecassis MM
J Gen Virol; 2019 Dec; 100(12):1680-1694. PubMed ID: 31647403
[TBL] [Abstract][Full Text] [Related]
5. New Insights Into the Molecular Mechanisms and Immune Control of Cytomegalovirus Reactivation.
Heald-Sargent TA; Forte E; Liu X; Thorp EB; Abecassis MM; Zhang ZJ; Hummel MA
Transplantation; 2020 May; 104(5):e118-e124. PubMed ID: 31996662
[TBL] [Abstract][Full Text] [Related]
6. How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future.
Sissons JG; Wills MR
Med Microbiol Immunol; 2015 Jun; 204(3):307-16. PubMed ID: 25896527
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
[TBL] [Abstract][Full Text] [Related]
8. Pediatric roots of cytomegalovirus recurrence and memory inflation in the elderly.
Adler SP; Reddehase MJ
Med Microbiol Immunol; 2019 Aug; 208(3-4):323-328. PubMed ID: 31062089
[TBL] [Abstract][Full Text] [Related]
9. The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
Wills MR; Poole E; Lau B; Krishna B; Sinclair JH
Cell Mol Immunol; 2015 Mar; 12(2):128-38. PubMed ID: 25132454
[TBL] [Abstract][Full Text] [Related]
10. A model for reactivation of CMV from latency.
Hummel M; Abecassis MM
J Clin Virol; 2002 Aug; 25 Suppl 2():S123-36. PubMed ID: 12361763
[TBL] [Abstract][Full Text] [Related]
11. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
[TBL] [Abstract][Full Text] [Related]
12. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
[TBL] [Abstract][Full Text] [Related]
13. The Role of the Human Cytomegalovirus
Mlera L; Moy M; Maness K; Tran LN; Goodrum FD
Viruses; 2020 Jul; 12(7):. PubMed ID: 32630219
[TBL] [Abstract][Full Text] [Related]
14. CD34
Crawford LB; Hancock MH; Struthers HM; Streblow DN; Yurochko AD; Caposio P; Goodrum FD; Nelson JA
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177198
[TBL] [Abstract][Full Text] [Related]
15. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
Ogunjimi B; Theeten H; Hens N; Beutels P
J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
[TBL] [Abstract][Full Text] [Related]
16. Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.
Rak MA; Buehler J; Zeltzer S; Reitsma J; Molina B; Terhune S; Goodrum F
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089695
[TBL] [Abstract][Full Text] [Related]
17. Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.
Mansfield S; Dwivedi V; Byrd S; Trgovcich J; Griessl M; Gutknecht M; Cook CH
J Med Virol; 2016 Aug; 88(8):1408-16. PubMed ID: 26762116
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor.
Fietze E; Prösch S; Reinke P; Stein J; Döcke WD; Staffa G; Löning S; Devaux S; Emmrich F; von Baehr R
Transplantation; 1994 Sep; 58(6):675-80. PubMed ID: 7940686
[TBL] [Abstract][Full Text] [Related]
19. Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation.
Collins-McMillen D; Buehler J; Peppenelli M; Goodrum F
Viruses; 2018 Aug; 10(8):. PubMed ID: 30127257
[TBL] [Abstract][Full Text] [Related]
20. Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.
Gardner TJ; Tortorella D
Microbiol Mol Biol Rev; 2016 Sep; 80(3):663-77. PubMed ID: 27307580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
